Top Markets
Coin of the day
Great Novel Therapeutics Biotech & Medicals Great Novel Therapeutics Biotech & Medicals

Great Novel Therapeutics Biotech & Medicals

7427
Classifica tra le azioni #20756
Great Novel Therapeutics Biotech & Medicals specializes in crafting... Great Novel Therapeutics Biotech & Medicals specializes in crafting pharmaceutical solutions to combat advanced and treatment-resistant cancers. Their primary focus lies in the realm of cancer immunotherapy, encompassing the creation of compounds such as tumor microenvironment regulators, epigenetic immunoactivators, and immune-regulating multi-kinase inhibitors. The company was previously known as GNT Biotech & Medicals Corporation. Established in 2013, its headquarters are situated in Taipei City, Taiwan.
Prezzo delle azioni
$2.32
Capitalizzazione di mercato
$122.09M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
109.59%
Paese
TW
Scambia Great Novel Therapeutics Biotech & Medicals (7427)

Categoria

Rapporto P/S per Great Novel Therapeutics Biotech & Medicals (7427)
Rapporto P/S al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Great Novel Therapeutics Biotech & Medicals, il rapporto P/S attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/S per Great Novel Therapeutics Biotech & Medicals da 2026 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
Non abbastanza dati per le date fornite.
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH